Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract has been selected for a poster presentation at ...

GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial.GEN-1013 was studied in aggressive murine cancer models ...

ITALY / WEST GERMANY / SPAIN AKA PER UN PUGNO DI DOLLARI AVAILABLE ON BLU-RAY: MAY 12, from ARROW VIDEO RUNNING TIME: 99 mins ...

Inhibition of GSK-3β may inhibit tumor growth and improve survival through several complimentary mechanisms that include enhancement of chemotherapy activity, activation of innate anti-tumor immunity, ...

AI Proteins, a biotechnology company pioneering the development of de novo designed miniprotein therapeutics, will be sending four key scientists to present at PEGS Boston 2025, the leading ...

I. Posters Six posters have been accepted for presentation at EASL Congress mainly covering several of GENFIT’s assets positioned in ACLF and, including, GENFIT’s latest work on Real-World data in ...

Conventional wisdom that Monday is the most miserable day of the week has been turned on its head by researchers who have found that Tuesday is when most people are at their lowest ebb Researchers at ...

Log9 Materials went from making headlines for its bold claims around cutting-edge battery tech to completely falling apart?

I’m not a perfect man,” said the newly elected vice chair of the Republican Party of Florida, Jovanté Teague, “but I’m ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...

to keep a complex organism like humans alive, an immense number of new cells must be continuously produced. Up close, each of these cell divisions is nothing short of a ...